Niagen Bioscience, Inc. (FRA:OCD1)
Germany
· Delayed Price · Currency is EUR 5.35
+0.10 (1.90%)
At close: Dec 4, 2025
-25.17% (1Y)
| Market Cap | 460.13M |
| Revenue (ttm) | 106.29M |
| Net Income (ttm) | 17.41M |
| Shares Out | n/a |
| EPS (ttm) | 0.20 |
| PE Ratio | 26.43 |
| Forward PE | 29.49 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 50 |
| Open | 5.35 |
| Previous Close | 5.25 |
| Day's Range | 5.35 - 5.35 |
| 52-Week Range | 4.72 - 12.40 |
| Beta | n/a |
| RSI | 39.70 |
| Earnings Date | Mar 5, 2026 |